RI-MUHC leads study of antiviral use in children hospitalized for influenza
Findings show that influenza antivirals are underutilized in Canadian pediatric hospitals, despite national clinical...
RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021
Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21
RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study
New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease
App-based HIV self-testing program leads to rapid detection of new infections and efficient connection to care
A unique new study shows that self-testing with the HIVSmart! program...
New cancer screening tool may help childhood cancer survivors
A novel cancer predisposition screening tool shows promise in helping doctors better predict which childhood cancer survivors may be at risk of developing...
Promising development in the fight with cancer using artificial intelligence
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...
New G protein inhibitor identified, with potential for cancer therapies
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells
RI-MUHC researchers contribute to global study of babies born with birth defects
A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...
New Quebec study evaluates long-term complications of COVID-19
RI-MUHC researcher Thao Huynh has been awarded a grant from Pfizer to conduct the IMPACT QUEBEC COVID-19 Long Haul Study
RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...